City
Epaper

New blood test offers hope for early detection of Parkinson's disease

By IANS | Updated: April 12, 2025 12:21 IST

Jerusalem, April 12 Israeli researchers have developed a new RNA-based blood test for detecting Parkinson's disease long before ...

Open in App

Jerusalem, April 12 Israeli researchers have developed a new RNA-based blood test for detecting Parkinson's disease long before symptoms emerge.

Parkinson's is often diagnosed only after significant brain damage has occurred, when most relevant neurons are already lost, underscoring the need for early detection.

The new method, detailed in the journal Nature Aging, measures specific RNA fragments in the blood, Xinhua news agency reported.

It focuses on two key biomarkers: a repetitive RNA sequence that accumulates in Parkinson's patients, and mitochondrial RNA -- which declines as the disease progresses, said the Hebrew University of Jerusalem (HU).

"This discovery represents a major advancement in our understanding of Parkinson's disease and offers a simple, minimally invasive blood test as a tool for early diagnosis," said Prof. Hermona Soreq from the varsity.

"By focusing on tRFs, we've opened a new window into the molecular changes that occur in the earliest stages of the disease."

In experiments, the test successfully distinguished pre-symptomatic Parkinson's patients from healthy controls with an accuracy of 86 per cent, outperforming current diagnostic methods.

Notably, the study also found that levels of the first type of fragments drop after deep brain stimulation, linking them to disease mechanisms and treatment responses.

The researchers said that this discovery paves the way for early interventions and treatments that could change the course of the disease, potentially improving patient outcomes through timely diagnosis and care.

Lead researcher Nimrod Madrer emphasised the importance of early detection, noting that Parkinson's disease is often diagnosed only after significant brain damage has occurred.

"This test has the potential to alleviate the uncertainty faced by patients and clinicians, offering a reliable and rapid method to identify the disease in its earliest stages," Madrer stated.

Disclaimer: This post has been auto-published from an agency feed without any modifications to the text and has not been reviewed by an editor

Open in App

Related Stories

InternationalOver 11,000 Afghan refugees forcibly deported from Iran, Pakistan in single day

NationalSolidarity for Manipuri cinema; fundraising screening of 'Oitharei' nets Rs 2.27 lakh

Other SportsFIDE World Cup 2025: GM Javokhir Sindarov, GM Wei Yi secure Candidates' spots after winning semis

NationalAyodhya gears up for grand flag hoisting ceremony; flower sellers celebrate boost in livelihoods

International"I'm going to kill that son of a b**ch": Ex-CIA officer reveals Musharraf's angry response to AQ Khan selling Pakistan's nuclear secrets

Health Realted Stories

HealthNew Industrial Relations Code empowers workers, boosts ease of doing business

HealthNew Labour Code on Wages aims to safeguard workers, boost growth and jobs

HealthIndia reaffirms commitment to equity, climate justice and global solidarity

HealthSolar System is racing through space 3x faster than thought: Study

HealthTechnology essential to achieve universal health coverage in India: NHA official